$0.07 EPS Expected for BioSyent Inc. (RX); Menta Capital Decreased Its Pioneer Energy Svcs (PES) Holding

May 12, 2018 - By Peter Erickson

Analysts expect BioSyent Inc. (CVE:RX) to report $0.07 EPS on May, 24.They anticipate $0.01 EPS change or 16.67% from last quarter’s $0.06 EPS. V_RX’s profit would be $1.01 million giving it 35.82 P/E if the $0.07 EPS is correct. After having $0.10 EPS previously, BioSyent Inc.’s analysts see -30.00% EPS growth. It closed at $10.03 lastly. It is down 0.00% since May 12, 2017 and is . It has underperformed by 11.55% the S&P500.

Menta Capital Llc decreased Pioneer Energy Svcs Corp (PES) stake by 73.57% reported in 2017Q4 SEC filing. Menta Capital Llc sold 131,635 shares as Pioneer Energy Svcs Corp (PES)’s stock rose 10.20%. The Menta Capital Llc holds 47,295 shares with $144,000 value, down from 178,930 last quarter. Pioneer Energy Svcs Corp now has $392.87 million valuation. The stock increased 1.00% or $0.05 during the last trading session, reaching $5.05. About 685,918 shares traded or 24.52% up from the average. Pioneer Energy Services Corp. (NYSE:PES) has declined 28.95% since May 12, 2017 and is downtrending. It has underperformed by 40.50% the S&P500.

Menta Capital Llc increased Tjx Cos Inc New (NYSE:TJX) stake by 7,453 shares to 11,953 valued at $914,000 in 2017Q4. It also upped Calpine Corp (NYSE:CPN) stake by 55,705 shares and now owns 101,149 shares. Foundation Bldg Matls Inc was raised too.

Among 14 analysts covering Pioneer Energy (NYSE:PES), 8 have Buy rating, 0 Sell and 6 Hold. Therefore 57% are positive. Pioneer Energy had 34 analyst reports since July 31, 2015 according to SRatingsIntel. Seaport Global upgraded Pioneer Energy Services Corp. (NYSE:PES) on Wednesday, December 20 to “Buy” rating. The firm earned “Neutral” rating on Wednesday, June 21 by Seaport Global. The company was downgraded on Friday, October 13 by Goldman Sachs. On Friday, July 31 the stock rating was maintained by Howard Weil with “Sector Perform”. The rating was upgraded by Wells Fargo to “Outperform” on Monday, July 18. The rating was upgraded by Wunderlich to “Buy” on Monday, December 12. The firm has “Buy” rating given on Monday, March 5 by Piper Jaffray. The rating was upgraded by Raymond James on Wednesday, November 2 to “Mkt Perform”. The stock of Pioneer Energy Services Corp. (NYSE:PES) has “Buy” rating given on Friday, December 16 by Goldman Sachs. Jefferies maintained the shares of PES in report on Monday, July 11 with “Hold” rating.

BioSyent Inc., a specialty pharmaceutical company, acquires or in-licenses, develops, and sells various pharmaceutical and other healthcare products in Canada and internationally. The company has market cap of $145.39 million. The Company’s products include FeraMAX 150, an oral hematinic for the prevention and treatment of iron deficiency anaemia; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by menopause, stress, and chemotherapy; Proktis-M, a rectal suppository to help healing of the anus and rectum; Aguettant System for pre-filled syringes that are used for various injectable medications in hospital and acute care settings; and Cysview for the detection and management of papillary non-muscle invasive bladder cancer. It has a 27.86 P/E ratio. The company's products also comprise Cathejell Jelly 2% indicated for surface anesthesia and lubrication for various procedures, including male and female cystoscopies, catheterizations, and other endourethral operations; and endoscopies, proctoscopies, rectoscopies, and tracheal intubations, as well as used for the symptomatic treatment of pain in connection with cystitis and urethritis.

Pioneer Energy Services Corp. (NYSE:PES) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Peter Erickson

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: